Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome
Abstract There is no specific treatment for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome (PA-HSOS). It is not clear when transjugular intrahepatic portosystemic shunt (TIPS) should be implemented in PA-HSOS patients. This study aimed to evaluate the timing of TIPS using tot...
Guardado en:
Autores principales: | Fan Wu, Jiao Yu, Hongying Gan, Heng Zhang, Deying Tian, Dan Zheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/82541ac9b2ae4c7d9b3d533899a6ddf1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis
por: Claus Christian Pieper, et al.
Publicado: (2021) -
Cardiovascular magnetic resonance demonstrates structural cardiac changes following transjugular intrahepatic portosystemic shunt
por: Ulf K. Radunski, et al.
Publicado: (2021) -
Technical and Medium-Term Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt with Fluoroscopy and Additional Trans-abdominal Ultrasound Guidance
por: Shyamkumar N. Keshava, et al.
Publicado: (2021) -
Pyrrolizidine alkaloid toxicosis and hepatic encephalopathy in horses in Easter Island, Chile
por: Lohse,Jorge C., et al.
Publicado: (2018) -
Scientific Opinion on Pyrrolizidine alkaloids in food and feed
por: EFSA Panel on Contaminants in the Food Chain (CONTAM)
Publicado: (2011)